Insights from the First Five Years of the Prospective Ocular Tumor Study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Prospective Ocular Tumor Study (POTS) database has collected data on over 1,700 rare ocular tumors. This standardized approach is crucial for advancing ocular oncology research and improving patient outcomes.
Area Of Science
- Ophthalmology
- Oncology
- Rare Diseases
Background
- Standardized data collection is essential for advancing rare disease research.
- Ocular tumors represent a group of rare diseases requiring dedicated study.
- The Prospective Ocular Tumor Study (POTS) was established to address this need.
Purpose Of The Study
- To describe the establishment and initial data collection of the Prospective Ocular Tumor Study (POTS).
- To report on the demographics, tumor types, and initial findings from the POTS database.
- To highlight the value of standardized data collection in ocular oncology.
Main Methods
- The Prospective Ocular Tumor Study (POTS) captures all patients with ocular tumors at Mayo Clinic Rochester.
- Data collected include patient demographics, tumor characteristics, treatment, and outcomes.
- This report details data gathered from July 2019 to July 2024.
Main Results
- A total of 1,766 patients were enrolled in the POTS database over a 5-year period.
- The most common ocular tumors identified were choroidal melanoma (34%) and choroidal nevus (32%).
- Other frequent diagnoses included iris nevus, iris melanoma, and vitreoretinal lymphoma.
Conclusions
- The POTS database provides a valuable resource for detailed, longitudinal data on rare ocular tumors.
- Expanding standardized data collection to multiple centers is recommended.
- Such expansion will facilitate improved outcomes research in the field of ocular oncology.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.